DEXCEL PHARMA TECHNOLOGIES LTD. et al v. APOTEX CORP. et al > Summary
Court Case Number 2:17-cv-02423
Filing Date Apr 7, 2017
Termination Date Nov 6, 2018
Court New Jersey District Court
Status Dismissed - Voluntarily
JudgesSusan D. Wigenton, Leda D. Wettre
Plaintiff
Defendant
Plaintiff Attorneys
12Dexcel Pharma
Attorney Name: William C. Baton
Saul Ewing LLP
Dexcel Pharma
Attorney Name: Brian Forsatz
Quinn Emanuel Urquhart & Sullivan
Dexcel Pharma
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Dexcel Pharma
Attorney Name: Catherine T. Mattes
Quinn Emanuel Urquhart & Sullivan
Dexcel Pharma
Attorney Name: Thomas D. Pease
Quinn Emanuel Urquhart & Sullivan
Dexcel Pharma
Attorney Name: Elina Slavin
Saul Ewing LLP
Dexcel Pharma
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Dexcel Pharma
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Dexcel Pharma
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan
Dexcel Pharma
Attorney Name: Evangeline L. Shih
Quinn Emanuel Urquhart & Sullivan
Dexcel Pharma
Attorney Name: Robert F. Green
Green, Griffith & Associates LLP
Dexcel Pharma
Attorney Name: Caryn Borg-Breen
Green, Griffith & Associates LLP
Defendant Attorneys
Apotex
Attorney Name: Ryan P. Blaney
Cozen O'Connor
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09023391 | Stable benzimidazole formulation | May 5, 2015 |
| 07255878 | Stable benzimidazole formulation | Aug 14, 2007 |
